DNTH logo

Dianthus Therapeutics (DNTH)

Profile

Full Name

Dianthus Therapeutics, Inc.

Ticker Symbol

DNTH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 21, 2018

Indexes

Not included

Website

http://dianthustx.com

Employees

78

Key Details

Price

$16.33(+9.89%)

Market cap

$524.60M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$6.24M(+120.63% YoY)

Annual EPS

-$2.55(+69.82% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$16.33
DNTH price is $16.33

30-Day Relative Volume

2.22
DNTH 30-day relative volume is 2.22

Price Performance

Price Most recent change

+9.89%
DNTH price was up +9.89% on Apr 9, 2025

Price YTD change

-25.09%
DNTH price is down -25.09% since January 1st

Price 1-year change

-32.3%
DNTH price is down -32.3% year-on-year

Price 3-year change

+537.89%
DNTH price is up +537.89% over the past 3 years

Price Range

Price All-time high

$33.77
DNTH price is currently -51.64% below its historical high of $33.77

Price 3-year low

$0.32
DNTH price is currently +5003.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$524.60M
DNTH market capitalization is $524.60 million

Market cap 3-year change

-
DNTH market capitalization 3-year change is unknown

Market cap All-time high

$950.84M
DNTH market capitalization is currently -44.83% below its historical high of $950.84 million

Market cap sector rank

70.17%
DNTH market capitalization is higher than 70.17% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+9.46%
DNTH shares outstanding is up +9.46% year-on-year

Shares Outstanding 3-Year Change

-
DNTH shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.26
DNTH beta is 1.26

200-day SMA

$24.95
DNTH price is currently -34.54% below its 200-day simple moving average

50-day SMA

$21.08
DNTH price is currently -22.52% below its 50-day simple moving average

RSI

38.17
DNTH 14-day relative strength index is 38.17

Volume

2.22
DNTH 30-day relative volume is 2.22

ATR

$2.11
DNTH average true range is $2.11

10-day Historical Volatility

109.06%
DNTH 10-day historical volatility is 109.06%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$6.24M
DNTH annual revenue is $6.24 million

Revenue Analysts estimate

$3.52M
DNTH annual revenue is currently +77.38% higher than the consensus analysts' forecast

Revenue 1-year change

+120.63%
DNTH annual revenue is up +120.63% year-on-year

Revenue Sector rank

22.71%
DNTH annual revenue is higher than 22.71% of companies in Healthcare sector

EPS

EPS

-$2.55
DNTH annual earnings per share is -$2.55

EPS Analysts estimate

-$3.16
DNTH annual earnings per share is currently -19.30% lower than the consensus analysts' forecast

EPS 1-year change

+69.82%
DNTH annual earnings per share is up +69.82% year-on-year

EPS Sector rank

33.47%
DNTH annual earnings per share is higher than 33.47% of companies in Healthcare sector

Profit

Gross profit

-
DNTH annual gross profit value is unknown

Gross margin

-
DNTH annual gross profit margin value is unknown

Operating profit

-$101.86M
DNTH annual operating income is -$101.86 million

Operating margin

-1633.75%
DNTH annual operating profit margin is -1633.75%

Net income

-$84.97M
DNTH annual net profit is -$84.97 million

Net margin

-1362.77%
DNTH annual net profit margin is -1362.77%

Expenses

Total expenses

$108.10M
DNTH annual total expenses is $108.10 million

Operating expenses

$108.10M
DNTH annual total operating expenses is $108.10 million

Cost of goods sold

-
DNTH annual cost of goods sold value is unknown

Selling, general & administrative expenses

$24.99M
DNTH annual SGA is $24.99 million

Depreciation and amortization

$412.00K
DNTH annual depreciation & amortization is $412.00 thousand

Interest expense

-
DNTH annual interest expense value is unknown

Income tax

-
DNTH annual income tax value is unknown

EBIT & EBITDA

EBIT

-$101.86M
DNTH annual earnings before interest & taxes is -$101.86 million

EBITDA

-$101.45M
DNTH annual EBITDA is -$101.45 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$374.01M
DNTH annual total assets is $374.01 million

Non current assets

$93.10M
DNTH annual long term assets is $93.10 million

Current assets

$280.90M
DNTH annual total current assets is $280.90 million

Cash and cash equivalents

$22.79M
DNTH annual cash & cash equivalents is $22.79 million

Accounts receivable

-
DNTH annual accounts receivable value is unknown

Inventory

-
DNTH annual inventory value is unknown

Liabilities

Total liabilities

$21.53M
DNTH annual total liabilities is $21.53 million

Long term liabilities

$3.08M
DNTH annual total long term liabilities is $3.08 million

Current liabilities

$18.45M
DNTH annual total current liabilities is $18.45 million

Accounts payable

$4.58M
DNTH annual accounts payable is $4.58 million

Debt

Total debt

$1.49M
DNTH annual total debt is $1.49 million

Total debt 1-year change

+154.87%
DNTH annual total debt is up +154.87% year-on-year

Long term debt

$1.17M
DNTH annual long term debt is $1.17 million

Short term debt

$320.00K
DNTH annual short term debt is $320.00 thousand

Equity & Capital

Shareholders equity

$352.48M
DNTH annual stockholders equity is $352.48 million

Book value

$352.48M
DNTH annual book value is $352.48 million

Retained earnings

-$174.39M
DNTH annual retained earnings is -$174.39 million

Working capital

$262.45M
DNTH annual working capital is $262.45 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$78.18M
DNTH annual cash flow from operations is -$78.18 million

Cash from operations 1-year change

-112.09%
DNTH annual cash flow from operations is down -112.09% year-on-year

Cash from investing

-$286.81M
DNTH annual cash flow from investing activities is -$286.81 million

Cash from investing 1-year change

-1516.15%
DNTH annual cash flow from investing activities is down -1516.15% year-on-year

Cash from financing

$255.62M
DNTH annual cash flow from financing activities is $255.62 million

Cash from financing 1-year change

+91.37%
DNTH annual cash flow from financing activities is up +91.37% year-on-year

CAPEX

CAPEX

$105.00K
DNTH annual capital expenditures is $105.00 thousand

CAPEX 1-year change

-4.55%
DNTH annual capital expenditures is down -4.55% year-on-year

Free Cash Flow

Free cash flow

-$78.28M
DNTH annual free cash flow is -$78.28 million

Free cash flow 1-year change

-111.75%
DNTH annual free cash flow is down -111.75% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DNTH annual gross profit margin value is unknown

Operating margin

-1633.75%
DNTH annual operating profit margin is -1633.75%

Net margin

-1362.77%
DNTH annual net profit margin is -1362.77%

ROA & ROE

ROA

-30.71%
DNTH annual return on assets is -30.71%

ROE

-32.60%
DNTH annual return on equity is -32.60%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DNTH price to earnings ratio value is unknown

PE ratio Sector rank

-
DNTH price to earnings ratio is unknown

PB Ratio

PB ratio

1.49
DNTH price to book ratio is 1.49

PB ratio Sector rank

55.59%
DNTH price to book ratio is higher than 55.59% of companies in Healthcare sector

PS Ratio

PS ratio

84.14
DNTH price to sales ratio is 84.14

PS ratio Sector rank

94.74%
DNTH price to sales ratio is higher than 94.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$503.30M
DNTH enterprise value is $503.30 million

Enterprise value Sector rank

69.91%
DNTH enterprise value is higher than 69.91% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.96
DNTH EV/EBITDA is -4.96

EV/EBITDA Sector rank

17.97%
DNTH EV/EBITDA is higher than 17.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

15.22
DNTH annual current ratio is 15.22

Quick ratio

-
DNTH annual quick ratio value is unknown

Leverage

Debt to equity

0.00
DNTH annual debt to equity ratio is 0.00

Interest coverage ratio

-
DNTH annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DNTH piotroski f-score value is unknown

Altman Z-Score

13.93
DNTH altman z-score is 13.93

Analyst ratings

Recent major analysts updates

Mar 12, 25 Wedbush
Outperform
Mar 12, 25 HC Wainwright & Co.
Buy
Mar 12, 25 Guggenheim
Buy
Dec 20, 24 TD Cowen
Buy
Nov 11, 24 Oppenheimer
Outperform
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Raymond James
Outperform
Oct 3, 24 Oppenheimer
Outperform
Sep 26, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

OPT logo
Opthea Limited (OPT)
BVS logo
Bioventus (BVS)
TRVI logo
Trevi Therapeutics (TRVI)
ANAB logo
AnaptysBio (ANAB)
ORGO logo
Organogenesis Holdings (ORGO)
SLP logo
Simulations Plus (SLP)
KALV logo
KalVista Pharmaceuticals (KALV)
IMNM logo
Immunome (IMNM)
COGT logo
Cogent Biosciences (COGT)
  • What is the ticker symbol for Dianthus Therapeutics?
  • Does Dianthus Therapeutics pay dividends?
  • What sector is Dianthus Therapeutics in?
  • What industry is Dianthus Therapeutics in?
  • What country is Dianthus Therapeutics based in?
  • When did Dianthus Therapeutics go public?
  • Is Dianthus Therapeutics in the S&P 500?
  • Is Dianthus Therapeutics in the NASDAQ 100?
  • Is Dianthus Therapeutics in the Dow Jones?
  • When was Dianthus Therapeutics's last earnings report?
  • When does Dianthus Therapeutics report earnings?
  • Should I buy Dianthus Therapeutics stock now?

What is the ticker symbol for Dianthus Therapeutics?

The ticker symbol for Dianthus Therapeutics is NASDAQ:DNTH

Does Dianthus Therapeutics pay dividends?

No, Dianthus Therapeutics does not pay dividends

What sector is Dianthus Therapeutics in?

Dianthus Therapeutics is in the Healthcare sector

What industry is Dianthus Therapeutics in?

Dianthus Therapeutics is in the Biotechnology industry

What country is Dianthus Therapeutics based in?

Dianthus Therapeutics is headquartered in United States

When did Dianthus Therapeutics go public?

Dianthus Therapeutics's initial public offering (IPO) was on June 21, 2018

Is Dianthus Therapeutics in the S&P 500?

No, Dianthus Therapeutics is not included in the S&P 500 index

Is Dianthus Therapeutics in the NASDAQ 100?

No, Dianthus Therapeutics is not included in the NASDAQ 100 index

Is Dianthus Therapeutics in the Dow Jones?

No, Dianthus Therapeutics is not included in the Dow Jones index

When was Dianthus Therapeutics's last earnings report?

Dianthus Therapeutics's most recent earnings report was on Mar 11, 2025

When does Dianthus Therapeutics report earnings?

The next expected earnings date for Dianthus Therapeutics is May 9, 2025

Should I buy Dianthus Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page